India Pacemaker Market Report, 2026–2034: Share, Technology Advancements and Outlook

How Is the India Pacemaker Market Performing?

India is home to a fast-growing base of pacemaker manufacturers in India and device developers, as the market undergoes steady expansion driven by the increasing incidence of cardiovascular diseases, a growing aging population, and enhanced awareness of heart health. Government efforts toward making medical devices more affordable, alongside rising demand for less invasive treatment options, are further fueling market growth.

The market size reached USD 195.1 Million in 2025 and is projected to reach USD 294.9 Million by 2034, growing at a CAGR of 4.70% during 2026–2034. Continued innovation in biocompatible materials, leadless technology, and affordability-focused manufacturing is reshaping how cardiac care is delivered across the country.

Market Snapshot

• Market Size (2025): USD 195.1 Million
• Forecast Value (2034): USD 294.9 Million
• CAGR (2026–2034): 4.70%
• Product Types Covered: Implantable Pacemaker, External Pacemaker
• Technologies Covered: Single Chambered, Dual Chambered, Three Lead Pacemaker

What Growth Factors Are Driving the India Pacemaker Market?

• Growing Preference for Biocompatible and Advanced Pacemaker Technologies:

With medical technology constantly improving, pacemakers are becoming more efficient, smaller, and capable of delivering improved outcomes. Older-generation pacemakers are increasingly being replaced by newer models offering MRI-compatibility, leadless design, and more advanced monitoring algorithms, minimizing complications and enhancing patient quality of life. As India's leadless pacemaker segment expands, Abbott introduced the AVEIR VR single-chamber ventricular leadless pacemaker in the country in November 2024, targeting patients with slow heart rhythms, with approval from India's Central Drugs Standard Control Organization (CDSCO) as well as the US FDA.

• Increase in Affordable Pacemaker Solutions:

As India's healthcare industry grows, domestic and international players are increasingly focused on manufacturing low-cost pacemakers to reach the country's large, price-conscious population. Government programs such as Ayushman Bharat Yojana, alongside efforts by public and private healthcare facilities, are contributing significantly to making medical devices more affordable. In November 2024, researchers at the Birla Institute of Technology and Science (BITS) developed a battery-free "fuel cell" for powering pacemakers, presenting a possible alternative to costly lithium-ion batteries that require regular replacement.

Evaluate Market Opportunity with the Business Sample Report

What Opportunities Lie Ahead for the India Pacemaker Market?

The India pacemaker market is positioned for continued growth through 2034, supported by rising cardiovascular disease incidence, an aging population, and expanding access to affordable cardiac care. Strategic collaborations between global medical device companies and domestic partners — such as the February 2025 memorandum of understanding between MicroPort CRM, the Andhra Pradesh MedTech Zone (AMTZ), and Purple MicroPort to expand pacemaker operations in India — reflect the growing investment interest in the country's cardiac rhythm management ecosystem. Companies that invest in leadless technology, battery innovation, and affordability-focused manufacturing are well placed to capture above-market returns as demand for advanced, less invasive cardiac devices accelerates.

How Is the India Pacemaker Market Segmented?

By Product Type:

• Implantable Pacemaker
• External Pacemaker

Implantable pacemakers are surgically placed devices designed for long-term cardiac rhythm management, while external pacemakers provide temporary pacing support, typically used in emergency or short-term clinical settings.

By Technology:

• Single Chambered
• Dual Chambered
• Three Lead Pacemaker

Single-chambered devices pace one heart chamber, dual-chambered devices coordinate pacing across two chambers for more natural rhythm control, and three-lead (biventricular) systems are used in more complex cardiac resynchronization therapy applications.

By Application:

• Heart Block
• Arrhythmia
• Others

By Region:

• North India
• South India
• East India
• West India

The report has provided a comprehensive analysis of all major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape

The report offers an in-depth examination of the competitive landscape, including market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Investment & Growth Opportunities

• Leadless pacemaker technology development and commercialization, addressing rising demand for minimally invasive cardiac devices
• Battery-free and alternative power innovation aimed at reducing long-term replacement costs for patients
• Affordable manufacturing partnerships aligned with government healthcare affordability programs
• Regional expansion of cardiac rhythm management infrastructure across underserved parts of India

India Pacemaker Market Recent Developments & News

• February 2025: MicroPort CRM, Andhra Pradesh MedTech Zone (AMTZ), and Purple MicroPort entered into a Memorandum of Understanding to facilitate the growth of MicroPort CRM's pacemaker operations in India and surrounding nations, aiming to meet rising demand for cardiac rhythm management devices.

Source: IMARC Group

As a market analyst with a deep understanding of economic and financial principles, I specialize in uncovering market trends and delivering data-driven insights to inform strategic business decisions. My academic background in economics and finance,